- Report
- December 2025
- 200 Pages
Global
From €7168EUR$7,950USD£6,218GBP
- Report
- November 2025
- 200 Pages
Global
From €7168EUR$7,950USD£6,218GBP
- Report
- November 2025
- 200 Pages
Global
From €7168EUR$7,950USD£6,218GBP
- Report
- August 2025
- 225 Pages
Global
From €2254EUR$2,500USD£1,955GBP
- Report
- February 2026
- 305 Pages
Global
From €2254EUR$2,500USD£1,955GBP
- Report
- January 2026
- 299 Pages
Global
From €2254EUR$2,500USD£1,955GBP
- Report
- August 2025
- 188 Pages
Global
From €4058EUR$4,500USD£3,519GBP
- Report
- June 2025
- 150 Pages
Global
From €2434EUR$2,699USD£2,111GBP
- Report
- June 2026
- 388 Pages
Global
From €5275EUR$5,850USD£4,575GBP
- Report
- January 2026
- 180 Pages
Global
From €4058EUR$4,500USD£3,519GBP
- Report
- October 2025
- 160 Pages
Global
From €3562EUR$3,950USD£3,089GBP
- Report
- August 2025
- 144 Pages
Global
From €3742EUR$4,150USD£3,246GBP
- Report
- August 2025
- 156 Pages
Global
From €3742EUR$4,150USD£3,246GBP
- Report
- January 2026
- 153 Pages
Global
From €3562EUR$3,950USD£3,089GBP
- Report
- August 2025
- 145 Pages
Global
From €3562EUR$3,950USD£3,089GBP
- Report
- November 2025
- 210 Pages
Global
From €4373EUR$4,850USD£3,793GBP
- Clinical Trials
- March 2026
- 145 Pages
Global
From €3111EUR$3,450USD£2,698GBP
- Clinical Trials
- February 2026
- 1549 Pages
Global
From €3111EUR$3,450USD£2,698GBP
- Clinical Trials
- December 2025
- 219 Pages
Global
From €3111EUR$3,450USD£2,698GBP
- Clinical Trials
- December 2025
- 636 Pages
Global
From €3111EUR$3,450USD£2,698GBP

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists.
The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more